AXP vs MRNA · P/E 20, rev $21.73B vs rev $145.0M
American Express Company (AXP) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US. It is led by Stephen Joseph Squeri.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the AXP and MRNA stock pages for the full models.
Not investment advice.